News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Outcomes in patients with oligoprogression following 1st line IO or ChemoIO
Oct 7, 2024, 16:46

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Gerry Hanna, Radiation Oncologist at St James’s Hospital, shared a post on X:

“Very intresting paper by Lauren Julia Brown, Harriet Gee, Eric Hau from Australia. They report outcomes in patients with oligoprogression following 1st line IO or ChemoIO.
Patients who receive radiotherapy have better survival.
Paper link on JTO & JTO CRR.”

Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study

Authors: Lauren Julia Brown, et al.

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

 

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Source: Gerry Hanna/X

cancer cancer awareness cancer care Dublin Eric Hau fight against cancer Gerry Hanna Global fight against cancer Harriet Gee JTO & JTO CRR Lauren Julia Brown NSCLC OncoDaily Oncology radiotherapy St James's Hospital
Special Coverage
Blog
Dec 21, 2024, 08:18
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers?
Career
Dec 21, 2024, 08:12
Rishabh Singh: Honored to receive the Mary Draeger Schultz Scholarship 2024
Science
Dec 21, 2024, 07:56
Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer
Career
Dec 21, 2024, 07:45
OncoInfluencers to Follow on Social Media: Dr. Liang Cheng
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer
Science
Dec 21, 2024, 07:05
Naseema Gangat: Practical prognostic tool for the current standard of care in older/unfit AML
Blog
Dec 21, 2024, 05:54
LCC in Spanish: LALCA 2024 Highlights
Blog
Dec 21, 2024, 05:50
The Opportunities Are Endless: CU Cancer Center leader Enrique Soto Pérez de Celis signs key international agreement
Insight
Dec 21, 2024, 05:42
Raffaella Casolino: How to integrate cancer into crisis?
Insight
Dec 21, 2024, 05:01
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Blog
Dec 21, 2024, 05:01
Omolola Salako: A year ago, Pearl Oncology Specialist Hospital became a 24-hour, 10-bed cancer center
Science
Dec 21, 2024, 04:57
Alexandre Chan: Updates on repurposing riluzole as a treatment for cancer-related cognitive impairment